⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CERO News
CERo Therapeutics Holdings, Inc. Common Stock
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
globenewswire.com
CERO
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
globenewswire.com
CERO
CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML
globenewswire.com
CERO